Managing risks of TNF inhibitors

An update for the internist

Jennifer Hadam, Elie Aoun, Kofi Clarke, Mary Chester Wasko

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Tumor necrosis factor (TNF) inhibitors have many beneficial effects, but they also pose infrequent but significant risks, including serious infection and malignancy. These risks can be minimized by judicious patient selection, appropriate screening, careful monitoring during treatment, and close communication between primary care physicians and subspecialists.

Original languageEnglish (US)
Pages (from-to)115-127
Number of pages13
JournalCleveland Clinic journal of medicine
Volume81
Issue number2
DOIs
StatePublished - Feb 1 2014

Fingerprint

Tumor Necrosis Factor-alpha
Primary Care Physicians
Patient Selection
Communication
Infection
Neoplasms
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Hadam, Jennifer ; Aoun, Elie ; Clarke, Kofi ; Wasko, Mary Chester. / Managing risks of TNF inhibitors : An update for the internist. In: Cleveland Clinic journal of medicine. 2014 ; Vol. 81, No. 2. pp. 115-127.
@article{cd18533263164fd0961e4d354f0d1657,
title = "Managing risks of TNF inhibitors: An update for the internist",
abstract = "Tumor necrosis factor (TNF) inhibitors have many beneficial effects, but they also pose infrequent but significant risks, including serious infection and malignancy. These risks can be minimized by judicious patient selection, appropriate screening, careful monitoring during treatment, and close communication between primary care physicians and subspecialists.",
author = "Jennifer Hadam and Elie Aoun and Kofi Clarke and Wasko, {Mary Chester}",
year = "2014",
month = "2",
day = "1",
doi = "10.3949/ccjm.81a.12121",
language = "English (US)",
volume = "81",
pages = "115--127",
journal = "Cleveland Clinic Journal of Medicine",
issn = "0891-1150",
publisher = "Cleveland Clinic Educational Foundation",
number = "2",

}

Managing risks of TNF inhibitors : An update for the internist. / Hadam, Jennifer; Aoun, Elie; Clarke, Kofi; Wasko, Mary Chester.

In: Cleveland Clinic journal of medicine, Vol. 81, No. 2, 01.02.2014, p. 115-127.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Managing risks of TNF inhibitors

T2 - An update for the internist

AU - Hadam, Jennifer

AU - Aoun, Elie

AU - Clarke, Kofi

AU - Wasko, Mary Chester

PY - 2014/2/1

Y1 - 2014/2/1

N2 - Tumor necrosis factor (TNF) inhibitors have many beneficial effects, but they also pose infrequent but significant risks, including serious infection and malignancy. These risks can be minimized by judicious patient selection, appropriate screening, careful monitoring during treatment, and close communication between primary care physicians and subspecialists.

AB - Tumor necrosis factor (TNF) inhibitors have many beneficial effects, but they also pose infrequent but significant risks, including serious infection and malignancy. These risks can be minimized by judicious patient selection, appropriate screening, careful monitoring during treatment, and close communication between primary care physicians and subspecialists.

UR - http://www.scopus.com/inward/record.url?scp=84893914926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893914926&partnerID=8YFLogxK

U2 - 10.3949/ccjm.81a.12121

DO - 10.3949/ccjm.81a.12121

M3 - Review article

VL - 81

SP - 115

EP - 127

JO - Cleveland Clinic Journal of Medicine

JF - Cleveland Clinic Journal of Medicine

SN - 0891-1150

IS - 2

ER -